Photo Release -- Nasdaq Welcomes Cellectis SA (Nasdaq: CLLS) to The Nasdaq Stock Market
26 March 2015 - 2:05AM
Nasdaq (Nasdaq:NDAQ) announced that trading of Cellectis SA
(Nasdaq:CLLS) commenced on The Nasdaq Stock Market on March 25,
2015.
A photo accompanying this release is available
at http://resource.globenewswire.com/Resource/Download/1615fe01-5705-4231-9e12-3cb7b5bff6c0
Cellectis is a pioneering gene-editing company focused on
developing immunotherapies based on gene edited engineered CAR-T
cells (UCART). Cellectis is dedicated to developing new types
of cancer therapies based on these cells. The Company’s
gene-editing technologies give the ability to create allogeneic CAR
T-cells, meaning they are derived from healthy donors rather than
the patients themselves.
“Cellectis is innovating in the field of cancer treatment by
harnessing the immune system to target and eradicate cancers,” said
Nelson Griggs, Executive Vice President, Listing Services,
Nasdaq. “We are excited to welcome Cellectis to the Nasdaq
family and congratulate them on their initial public offering.”
By listing with Nasdaq, Cellectis joins some of the world’s
largest and most revolutionary healthcare companies. Nasdaq is the
exchange of choice to 72 percent of healthcare companies and 57
percent of European companies listed in the U.S. Markets.
The information contained above is provided for informational
and educational purposes only, and nothing contained herein should
be construed as investment advice, either on behalf of a particular
security or an overall investment strategy. Neither Nasdaq nor any
of its affiliates makes any recommendation to buy or sell any
security or any representation about the financial condition of any
company. Statements regarding Nasdaq-listed companies are not
guarantees of future performance. Actual results may differ
materially from those expressed or implied. Past performance is not
indicative of future results. Investors should undertake their own
due diligence and carefully evaluate companies before investing.
ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
About Nasdaq:
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing,
exchange technology, listing, information and public company
services across six continents. Through its diverse portfolio of
solutions, Nasdaq enables customers to plan, optimize and execute
their business vision with confidence, using proven technologies
that provide transparency and insight for navigating today's global
capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 70
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to more than 3,500 listed companies
with a market value of over $9.1 trillion and more than 10,000
corporate clients. To learn more, visit
http://nasdaq.com/ambition or
http://business.nasdaq.com.
NDAQG
MEDIA RELATIONS CONTACT:
Will Briganti
(646) 441-5012
william.briganti@nasdaq.com
Christine Barna
(646) 441-5310
Christine.Barna@nasdaq.com
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2024 to May 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From May 2023 to May 2024